Treatment of dissociative identity disorder: leveraging neurobiology to optimize success

Juliann B. Purcell,Bethany Brand,Heidi A. Browne,Richard A. Chefetz,Meghan Shanahan,Zoe A. Bair,Kim A. Baranowski,Vona Davis,Patricia Mangones,Rebecca L. Modell,Cori A. Palermo,Emma C. Robertson,Matthew A. Robinson,Laura Ward,Sherry Winternitz,Milissa L. Kaufman,Lauren A. M. Lebois
DOI: https://doi.org/10.1080/14737175.2024.2316153
IF: 4.287
2024-02-17
Expert Review of Neurotherapeutics
Abstract:Introduction Dissociative identity disorder (DID) is a treatable mental health condition that is associated with a range of psychobiological manifestations. However, historical controversy, modern day misunderstanding, and lack of professional education have prevented accurate treatment information from reaching most clinicians and patients. These obstacles also have slowed empirical efforts to improve treatment outcomes for people with DID. Emerging neurobiological findings in DID provide essential information that can be used to improve treatment outcomes.
pharmacology & pharmacy,clinical neurology
What problem does this paper attempt to address?